Journals / Dicle Tıp Dergisi / 2006 / Cilt: 33 - Sayı: 2

Therapeutical potential of venom peptides

Terapötik potansiyele sahip venom peptidleri

Pages
113–126
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore particularly in clinical approaches, these peptide molecules or their synthetic analogues are considered as alternative agents that can be used instead of classical drugs for many clinical disorders due to their potent activity besides very few side effects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The term of pharmazooticals is known as a few amount of drugs derived from natural sources such as plants, venomous species of snakes, spiders, scorpions, frogs, lizards and cone snails.
📊
Key Findings & Data:Peptide components of venoms are directed against wide variety of pharmacological targets such as ion channels and receptors.
💡
Conclusion & Impact:Therefore particularly in clinical approaches, these peptide molecules or their synthetic analogues are considered as alternative agents that can be used instead of classical drugs for many clinical disorders due to their potent activity besides very few side effects.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Peptidler · Zehirler · Peptides

Abstract

The term of pharmazooticals is known as a few amount of drugs derived from natural sources such as plants, venomous species of snakes, spiders, scorpions, frogs, lizards and cone snails. Peptide components of venoms are directed against wide variety of pharmacological targets such as ion channels and receptors. At the beginning, a number of these peptides have been used in experimental studies for defining the physiological, biochemical and immunological activities of organisms like mammalians. In recent studies, it has been shown that venom peptides can be valuable in treatment of acute and chronic pain, autoimmune and cardiovascular diseases, neurological disorders and chronic inflammatory and tumoral processes. Therefore particularly in clinical approaches, these peptide molecules or their synthetic analogues are considered as alternative agents that can be used instead of classical drugs for many clinical disorders due to their potent activity besides very few side effects.

Özet

Farmazootikler doğal kaynaklardan elde edilen az sayıdaki ilacı tanımlamada kullanılan bir terimdir. Söz konusu doğal kaynaklar bitkiler ve zehirli yılan, akrep, örümcek, kurbağa, kertenkele ve deniz canlısı türleri olarak sayılabilirler. Zehirin peptid yapılı bileşenleri iyon kanalları ve reseptörler gibi çeşitli farmakolojik hedefler üzerinden etkilerini gösterirler. Bu tarz etkilerinden dolayı zehir bileşimindeki peptidler başlangıçta, memeliler gibi organizmaların fizyolojik, biyokimyasal ve immünolojik faaliyetlerinin tanımlanmasında kullanılmıştır. Son dönemde yapılan çalışmalarda peptid bileşenlerinin otoimmün, kronik enflamatuar, kardiyovasküler, nörolojik ve tümöral hastalıkların tedavisinde de etkili olabildiği gösterilmiştir. Bu bakımdan özellikle klinik uygulamalarda venom peptidlerine ya da sentetik türevlerine, gösterdikleri yüksek potensin yanında düşük yan etki potansiyellerinden dolayı günümüzün klasik ilaçlarının yerini alacakları gözüyle bakılmaktadır.

🔖

Cite This Article

KELLE, İ. (2006). Therapeutical potential of venom peptides. Dicle Tıp Dergisi, Cilt: 33 - Sayı: 2, 113–126. https://ajindex.com/articles/349664

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Skarnulis L, Nazario B. Wonder drugs using pharmazooticals. WebMD Inc., 2003 Aug.http://www.webmd.com/content/article/78 /95687.htm 2. Lewis RJ, Garcia ML. Therapeutic potential of venom peptides. Nature reviews. Drug discovery., 2003
  2. http://www.imb.uq.edu.au/download/large/Veno m_therapeutics.pdf 3. Albers T. Micro-screening of venoms. 2002 July:28. http://www.venomstodrugs.com/Venoms_Abstra ct_book.pdf 4. Ely T. Conotoxins reveal significant psychopharmacological effectiveness: the future of pain management. Journal of Psychology and Behavioral Sciences, 2003
  3. 18 http://www.alpha.fdu.edu/psychweb/Vol16- 17/Ely_Proof.pdf 5. From bites and stings to medicines. http://www.chemsoc.org/chembytes/ezine/199 9/berressem_apr99.htm 6. Lewis RJ, Nielsen C, Ross F, Drinkwater R, Alewood P, Smith M. Therapeutic potential of ω- and χ-conotoxins. 2002 July:34. http://www.venomstodrugs.com/Venoms_Abst ract_book.pdf 7. http://www.neuro.wustl.edu/neuromuscu lar/mother/chan.html 8. http://www.nature.com/bjp/journal/v144/ n1s/pdf/0706161a.pdf 9.Craik DJ, Clark R, Daly NL. Circular protein toxins – no end(s) in sight. 2002 July:11. http://www.venomstodrugs.com/Venoms_Abst ract_book.pdf 10. http://www.cyclotide.com/what.html 11. Browne DL, Gancher ST, Nutt JG, et al. Episodic ataxia / myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet. 1994
  4. Adelman JP, Bond CT, Pessia M, Maylie J. Episodic ataxia results from voltagedependent potassium channels with altered functions. Neuron. 1995
  5. Wulff H, Calabresi PA, Yun S, et al. Blockade of Kv1.3 channels in myeline reactive T cells as a therapeutic target for multiple sclerosis. 2002:33. 14. Effective new autoimmune disease drugs to use scorpion venom. http://thyroid.about.com/library/weekly/aa0718 00a.htm 15. Swenson S, Costa F, Minea R, et al. Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression. Mol Cancer Ther. 2004
  6. 511 16. Highfield R. Snake’s venom may help treat breast cancer. http://arachnophiliac.co.uk/burrow/news/snakes_venom_and_breast_cancer.htm 17. Scorpion venom might help in brain cancer – study. http://naturalhealthline.com/newsletter/HL 990201/venom.htm 18. Maruo VM, Lebrun I, Dorce VAC. Effects of scorpion Tityus serrulatus venom toxin TS-8F on rat learning and memory. J. Venom. Anim. Toxins, 2002
  7. http://www.ihop-net.org/UniPub/iHOP /gs